Tammy A Chin, MD
Psychiatry · Berkeley
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 11
- 1 carrier
- Office
- 1
- Since medical school
- 16 years
- University of California, San Francisco School of Medicine, 2010
Offices
1 location · Bay Psychiatric Associates · 60 clinicians in this group
Plans that list them
11 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chin’s office at (510) 204-4635 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A119061 · Current
Licensed to practise in California · since 2011 · expires 2027-04-30 · University of California San Francisco School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Psychiatry and Neurology - Psychiatry
Original Medicare doctor bills
$138,339
Medicare paid this office $138,339 for 43 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Office for the evaluation and management of an established patient that requires the supervision of a physician or other qualified health care professional and provision of greater than 56 mg esketamine nasal self-administration, | 20 | $89,835 | $1,302 |
| Return visit (30+ min) | 22 | $9,296 | $115 |
Who their Medicare patients are
43 Original Medicare patients in 2024. Average age 66 · Under 65 33% · Women 65% · Also on Medicaid 28% · Health risk score 1.10. At or below the middle of the specialty; the typical psychiatry clinician is at 1.35.
Conditions among them: Depression 75% · High blood pressure 49%.
The office billed $418,620, Medicare allowed $174,907 and paid $138,339; for 473 services of 12 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 43 | 473 | 66 | 1.10 | $418,620 | $138,339 |
| 2023 | 26 | 276 | 67 | 1.31 | $263,620 | $84,698 |
| 2022 | 30 | 238 | 70 | 1.12 | $115,690 | $25,526 |
| 2021 | 16 | 128 | 62 | 1.25 | $62,850 | $13,755 |
| 2020 | 33 | 347 | 69 | 1.79 | $174,220 | $34,772 |
| 2019 | 36 | 431 | 62 | 1.50 | $205,660 | $42,682 |
| 2018 | 34 | 447 | 61 | 1.18 | $234,310 | $44,792 |
| 2017 | 19 | 268 | 61 | 1.54 | $133,270 | $22,965 |
| 2016 | 18 | 61 | 63 | 1.38 | $22,100 | $4,706 |
| 2015 | 17 | 61 | 56 | 1.55 | $12,275 | $4,230 |
| 2014 | 14 | 136 | 57 | 1.19 | $27,900 | $9,090 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Office for the evaluation and management of an established patient that requires the supervision of a physician or other qualified health care professional and provision of greater than 56 mg esketamine nasal self-administration, | 13 | $50,600 | $1,265 |
2022: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $3,245 | $90 |
2020: 2 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $2,369 | $88 |
| Psychotherapy with evaluation and management visit, 30 minutes | 11 | $1,105 | $55 |
2019: 3 services
| Short return visit (20+ min) | 12 | $5,988 | $68 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $3,332 | $93 |
| Psychotherapy with evaluation and management visit, 30 minutes | 12 | $1,478 | $57 |
2018: 2 services
| Short return visit (20+ min) | 14 | $4,205 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $2,135 | $89 |
2017: 1 service
| Short return visit (20+ min) | 12 | $2,720 | $56 |
2015: 1 service
| Psychotherapy with evaluation and management visit, 30 minutes | 12 | $1,373 | $55 |
2014: 2 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $3,342 | $62 |
| Psychotherapy with evaluation and management visit, 30 minutes | 13 | $2,934 | $55 |
Drugs they prescribed that Part D paid
$18,545
Pharmacies billed $18,545 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 193) in 2024. At or below the middle of the specialty; the typical psychiatry clinician is at 0%.
178 generic and 15 brand-name prescriptions · $18,545 in drug cost · 13 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Mirtazapine | 29 | $720 | $25 |
| Duloxetine | 18 | $461 | $26 |
| Trazodone | 19 | $233 | $12 |
| Lamotrigine | 15 | $149 | $10 |
| Sertraline | 11 | $68 | $6 |
Year by year
| 2024 | 193 | 12 | 0% (0) | 8% | $18,545 |
| 2023 | 167 | None | 0% (0) | None | $10,481 |
| 2022 | 190 | None | 0% (0) | 7% | $8,958 |
| 2021 | 142 | None | 0% (0) | 8% | $8,157 |
| 2020 | 182 | None | 0% (0) | None | $7,740 |
| 2019 | 196 | 15 | 0% (0) | 9% | $15,615 |
| 2018 | 198 | 15 | 0% (0) | None | $8,114 |
| 2017 | 278 | 20 | None | 10% | $9,991 |
| 2016 | 245 | 20 | 0% (0) | 12% | $6,683 |
| 2015 | 68 | None | 0% (0) | 18% | $2,466 |
| 2014 | 29 | None | 0% (0) | None | $1,976 |
| 2013 | 199 | 18 | 0% (0) | 25% | $11,497 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Mirtazapine | 28 | $822 | $29 |
| Duloxetine | 27 | $309 | $11 |
| Lamotrigine | 17 | $175 | $10 |
| Sertraline | 12 | $75 | $6 |
2022: 7 drugs
| Trintellix | 12 | $5,704 | $475 |
| Mirtazapine | 30 | $816 | $27 |
| Duloxetine | 24 | $372 | $15 |
| Quetiapine | 18 | $277 | $15 |
| Lamotrigine | 18 | $218 | $12 |
| Venlafaxine Hcl Er | 13 | $93 | $7 |
| Sertraline | 13 | $83 | $6 |
2021: 6 drugs
| Trintellix | 12 | $6,169 | $514 |
| Mirtazapine | 16 | $426 | $27 |
| Duloxetine | 11 | $194 | $18 |
| Bupropion Xl | 12 | $128 | $11 |
| Lamotrigine | 14 | $89 | $6 |
| Sertraline | 11 | $28 | $3 |
2020: 6 drugs
| Mirtazapine | 18 | $420 | $23 |
| Quetiapine | 21 | $320 | $15 |
| Bupropion Xl | 11 | $245 | $22 |
| Trazodone | 11 | $212 | $19 |
| Sertraline | 25 | $116 | $5 |
| Lamotrigine | 17 | $115 | $7 |
2019: 7 drugs
| Trintellix | 12 | $4,647 | $387 |
| Mirtazapine | 13 | $571 | $44 |
| Quetiapine | 12 | $256 | $21 |
| Sertraline | 33 | $254 | $8 |
| Venlafaxine Hcl Er | 11 | $246 | $22 |
| Lamotrigine | 15 | $207 | $14 |
| Trazodone | 23 | $165 | $7 |
2018: 5 drugs
| Buspirone | 12 | $941 | $78 |
| Quetiapine | 22 | $617 | $28 |
| Lamotrigine | 27 | $251 | $9 |
| Sertraline | 35 | $209 | $6 |
| Escitalopram | 14 | $146 | $10 |
2017: 10 drugs
| Buspirone | 20 | $1,895 | $95 |
| Quetiapine | 27 | $866 | $32 |
| Bupropion Xl | 17 | $563 | $33 |
| Divalproex | 14 | $312 | $22 |
| Sertraline | 32 | $244 | $8 |
| Clonazepam | 22 | $216 | $10 |
| Escitalopram | 39 | $206 | $5 |
| Lithium Carbonate | 13 | $196 | $15 |
| Lamotrigine | 26 | $143 | $6 |
| Guanfacine | 11 | $43 | $4 |
2016: 9 drugs
| Buspirone | 20 | $1,443 | $72 |
| Divalproex | 18 | $523 | $29 |
| Quetiapine | 26 | $480 | $18 |
| Guanfacine | 11 | $405 | $37 |
| Clonazepam | 25 | $256 | $10 |
| Sertraline | 27 | $200 | $7 |
| Lithium Carbonate | 13 | $192 | $15 |
| Escitalopram | 37 | $144 | $4 |
| Trazodone | 13 | $111 | $9 |
2015: 2 drugs
| Quetiapine | 12 | $170 | $14 |
| Clonazepam | 12 | $91 | $8 |
2013: 7 drugs
| Cymbalta | 25 | $5,143 | $206 |
| Topiramate | 14 | $644 | $46 |
| Liothyronine | 13 | $439 | $34 |
| Buspirone | 13 | $220 | $17 |
| Temazepam | 18 | $175 | $10 |
| Trazodone | 16 | $137 | $9 |
| Sertraline | 12 | $101 | $8 |
Money from drug and device companies
$54 in 2019
A payment is not proof that care is biased.
| Neurocrine Biosciences | Ingrezza | $54 | 1 payment
|
See the published payment
| Neurocrine Biosciences | Meals · 2019-05-20 | Ingrezza | $54 |
Professional record
- NPI
- 1942521786
- Licence
- CA A119061California A119061: Current · expires 2027-04-30
- Trained
- University of California, San Francisco School of Medicine, 2010 · 16 years ago
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Psychiatry (2084P0800X)
- Mailing address
- 2020 Milvia St Ste 300, Berkeley, CA, 94704
- NPI first listed
- 2010-06-16
- NPI last updated
- 2016-02-23
This is when the NPI record was last certified, not a medical board exam.